<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2023-9-1-0-9</article-id><article-id pub-id-type="publisher-id">2989</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Geriatric management tactics for patients with diabetic retinopathy&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Geriatric management tactics for patients with diabetic retinopathy&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Lev</surname><given-names>Inna V.</given-names></name><name xml:lang="en"><surname>Lev</surname><given-names>Inna V.</given-names></name></name-alternatives><email>michina.inna@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Agarkov</surname><given-names>Nikolai M.</given-names></name><name xml:lang="en"><surname>Agarkov</surname><given-names>Nikolai M.</given-names></name></name-alternatives><email>vitalaxen@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Starodubtseva</surname><given-names>Liliya V.</given-names></name><name xml:lang="en"><surname>Starodubtseva</surname><given-names>Liliya V.</given-names></name></name-alternatives><email>bmi@yandex.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2023</year></pub-date><volume>9</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2023/1/Биомедицинские_исследования-130-142.pdf" /><abstract xml:lang="ru"><p>Background: Diabetic retinopathy remains one of the leading causes of visual impairment, however, the deficit profile of these patients, with the exception of cognitive and anxiety-depressive disorders, remains virtually unexplored. The geriatric tactics of managing patients with diabetic retinopathy also needs justification. The aim of the study: Substantiation and evaluation of the effectiveness of geriatric management tactics for patients with diabetic retinopathy. Materials and methods: In clinical conditions, 244 patients suffering from diabetic retinopathy were examined. In these patients a comprehensive ophthalmological and geriatric assessment was performed in accordance with the recommendations of the Russian Association of Gerontologists and Geriatricians. The leading clinical geriatric syndromes were studied in 244 patients with diabetic retinopathy and 200 patients without this disease. Taking into account the performed comprehensive geriatric assessment, the geriatric tactics of managing patients with diabetic retinopathy (main group, n=127) was scientifically substantiated and implemented. The control consisted of 117 patients with diabetic retinopathy who underwent standard therapeutic measures. Evaluation of the effectiveness of the treatment was carried out after 1 year. Results: In patients with diabetic retinopathy, the risk syndrome of falls was significantly more often diagnosed &amp;ndash; 64.2&amp;plusmn;3.1 versus 12.5&amp;plusmn;2.3 cases in patients without diabetic retinopathy per 100 examined, the syndrome of falls &amp;ndash; 45.0&amp;plusmn;3.2 cases versus 19.5&amp;plusmn;2.87 cases per 100 examined, anxiety-depressive syndrome 65.8&amp;plusmn;3.2 cases versus 41.5&amp;plusmn;3.5 cases per 100 examined, violations of general motor activity &amp;ndash; 47.9&amp;plusmn;3.2 versus 18.5&amp;plusmn;2.7 cases per 100 examined. The use of geriatric management tactics in the main group, including correction of visual deficit, fall syndrome and risk of falls, normalization of sleep, conducting courses of psychotherapy, the use of &amp;quot;Tykveol&amp;quot; to improve geriatric and oxidative status, the use of &amp;quot;Sulodexide&amp;quot; to correct hemocirculatory disorders, significantly reduced the frequency of deficiency syndromes and, above all, the syndrome of risk of falls to 34.4&amp;plusmn;4.2 vs. 60.0&amp;plusmn;4.6 cases per 100 treated in the control group, falls syndrome up to 23.2&amp;plusmn;3.8 cases vs. 36.5&amp;plusmn;4.5 cases, anxiety-depressive syndrome up to 32.8&amp;plusmn;4.2 cases versus 57.4&amp;plusmn;4.6 cases, respectively. Conclusion: Geriatric tactics of managing patients with diabetic retinopathy is more effective</p></abstract><trans-abstract xml:lang="en"><p>Background: Diabetic retinopathy remains one of the leading causes of visual impairment, however, the deficit profile of these patients, with the exception of cognitive and anxiety-depressive disorders, remains virtually unexplored. The geriatric tactics of managing patients with diabetic retinopathy also needs justification. The aim of the study: Substantiation and evaluation of the effectiveness of geriatric management tactics for patients with diabetic retinopathy. Materials and methods: In clinical conditions, 244 patients suffering from diabetic retinopathy were examined. In these patients a comprehensive ophthalmological and geriatric assessment was performed in accordance with the recommendations of the Russian Association of Gerontologists and Geriatricians. The leading clinical geriatric syndromes were studied in 244 patients with diabetic retinopathy and 200 patients without this disease. Taking into account the performed comprehensive geriatric assessment, the geriatric tactics of managing patients with diabetic retinopathy (main group, n=127) was scientifically substantiated and implemented. The control consisted of 117 patients with diabetic retinopathy who underwent standard therapeutic measures. Evaluation of the effectiveness of the treatment was carried out after 1 year. Results: In patients with diabetic retinopathy, the risk syndrome of falls was significantly more often diagnosed &amp;ndash; 64.2&amp;plusmn;3.1 versus 12.5&amp;plusmn;2.3 cases in patients without diabetic retinopathy per 100 examined, the syndrome of falls &amp;ndash; 45.0&amp;plusmn;3.2 cases versus 19.5&amp;plusmn;2.87 cases per 100 examined, anxiety-depressive syndrome 65.8&amp;plusmn;3.2 cases versus 41.5&amp;plusmn;3.5 cases per 100 examined, violations of general motor activity &amp;ndash; 47.9&amp;plusmn;3.2 versus 18.5&amp;plusmn;2.7 cases per 100 examined. The use of geriatric management tactics in the main group, including correction of visual deficit, fall syndrome and risk of falls, normalization of sleep, conducting courses of psychotherapy, the use of &amp;quot;Tykveol&amp;quot; to improve geriatric and oxidative status, the use of &amp;quot;Sulodexide&amp;quot; to correct hemocirculatory disorders, significantly reduced the frequency of deficiency syndromes and, above all, the syndrome of risk of falls to 34.4&amp;plusmn;4.2 vs. 60.0&amp;plusmn;4.6 cases per 100 treated in the control group, falls syndrome up to 23.2&amp;plusmn;3.8 cases vs. 36.5&amp;plusmn;4.5 cases, anxiety-depressive syndrome up to 32.8&amp;plusmn;4.2 cases versus 57.4&amp;plusmn;4.6 cases, respectively. Conclusion: Geriatric tactics of managing patients with diabetic retinopathy is more effective</p></trans-abstract><kwd-group xml:lang="ru"><kwd>diabetic retinopathy</kwd><kwd>geriatric syndromes</kwd><kwd>geriatric tactics</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetic retinopathy</kwd><kwd>geriatric syndromes</kwd><kwd>geriatric tactics</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. The Lancet Global Health. 2021;9(4):489-551. DOI: https://doi.org/10.1016/S2214-109X(20)30488-5</mixed-citation></ref><ref id="B2"><mixed-citation>Simo R, Stehouwer CDA, Avogaro A. Diabetic retinopathy: looking beyond the eyes. Diabetologia. 2020;63(8):1662-1664. DOI: https://doi.org/10.1016/10.1007/s00125-020-05195-4</mixed-citation></ref><ref id="B3"><mixed-citation>Gupta P, Gun AT, Man RE, et al. Association between diabetic retinopathy and incident cognitive impairment. British Journal of Ophthalmology. 2019;103(11):1605-1609. DOI: https://doi.org/10.1136/bjophthalmol-2018-312807</mixed-citation></ref><ref id="B4"><mixed-citation>Mathur R, Bhaskaran K, Edwards E, et al. Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014. BMJ open. 2017;7:e014444. DOI: https://doi.org/10.1136/bmjopen-2016-014444</mixed-citation></ref><ref id="B5"><mixed-citation>Ghaem H, Daneshi N, Riahi S, et al. The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran. Diabetes and Metabolism Journal. 2018;42(6):538-543. DOI: https://doi.org/10.4093/dmj.2018.0047</mixed-citation></ref><ref id="B6"><mixed-citation>Peng Y, Guo X, Liu J, et al. Incidence and risk factors for diabetic retinopathy in the communities of Shenzhen. Annals of palliative medicine. 2021;10(1):615-624. DOI: https://doi.org/10.21037/apm-20-2526</mixed-citation></ref><ref id="B7"><mixed-citation>Solomon SD, Chew E, Duh EJ, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412-418. DOI: https://doi.org/10.2337/dc16-2641</mixed-citation></ref><ref id="B8"><mixed-citation>Astakhov YuS, Neroyev VV, Shestakova MV, et al. Clinical recommendations &amp;quot;Diabetes mellitus: diabetic retinopathy, diabetic macular edema&amp;quot;. Moscow: Obshcherossiyskaya obshchestvennaya organizatsiya &amp;laquo;Assotsiatsiya vrachey-oftal&amp;#39;mologov&amp;raquo;; 2020. Russian.</mixed-citation></ref><ref id="B9"><mixed-citation>Gorelik SG, Ilnitsky AN, Proshaev KI, et al. Questionnaires and scales in gerontology and geriatrics. Gerontology. 2021;9(1):1-91. Russian.</mixed-citation></ref><ref id="B10"><mixed-citation>Order of the Ministry of Health of the Russian Federation No. 38n dated January 29, 2016 &amp;quot;On approval of the Procedure for providing medical care in the Geriatrics profile&amp;quot; [Internet] [cited 2022 Mar 24]. Russian. Available from: https://base.garant.ru/71351832/</mixed-citation></ref><ref id="B11"><mixed-citation>Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495. DOI: https://doi.org/10.1503/cmaj.050051</mixed-citation></ref><ref id="B12"><mixed-citation>Folstein MF, Folstein SE, McHugh RP. &amp;quot;Mini-mental state&amp;quot;. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189-198. DOI: https://doi.org/10.1016/0022-3956(75)90026-6</mixed-citation></ref><ref id="B13"><mixed-citation>Khanin YuL. The study of anxiety in sports. Voprosy Psychologii. 1978;5:94-106. Russian.</mixed-citation></ref><ref id="B14"><mixed-citation>Lu X, Gong W, Wen Z, et al. Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by&amp;nbsp;1H-MRS. Frontiers in Neurology. 2019;10:1068. DOI: https://doi.org/10.3389/fneur.2019.01068</mixed-citation></ref><ref id="B15"><mixed-citation>Goydin DA, Goydin AP, Fabrikantov OL. Effectiveness comparison of laser coagulation in diabetic retinopathy diff erent methods. Meditsina i fi zicheskaya kul&amp;rsquo;tura: nauka i praktika. 2019;1(1):28-33. Russian.</mixed-citation></ref><ref id="B16"><mixed-citation>Cheng D, Zhao X, Yang S, et al. Association Between Diabetic Retinopathy and Cognitive Impairment: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience. 2021;13:692911. DOI: https://doi.org/10.3389/fnagi.2021.692911</mixed-citation></ref><ref id="B17"><mixed-citation>Yu ZW, Liu R, Li X, et al. High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020;13:1359-1365. DOI: https://doi.org/10.2147/DMSO.S249126</mixed-citation></ref><ref id="B18"><mixed-citation>Zhang B, Wang Q, Zhang X, et al. Association between self-care agency and depression and anxiety in patients with diabetic retinopathy. BMC Ophthalmology. 2021;21(1):123. DOI: https://doi.org/10.1186/s12886-021-01883-w</mixed-citation></ref></ref-list></back></article>